DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» SPRY2
SPRY2
Sprouty2 Deficiency in Mice Leads to the Development of Achalasia Benjamin Lee Staal Grand Valley State University
Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma Alice M
Spry2 Regulates Signalling Dynamics and Terminal Bud Branching Behaviour During Lung Development
Sprouty Proteins, Masterminds of Receptor Tyrosine Kinase Signaling
T Cell Depending on the Differentiation State of the Dual
Spry1 and Spry2 Are Essential for Development of The
Thesis Resubmission Daphne Chen
Down-Regulation of Sprouty2 in Non–Small Cell Lung
SPRY2 Is an Inhibitor of the Ras/Extracellular Signal-Regulated Kinase Pathway in Melanocytes and Melanoma Cells with Wild-Type BRAF but Not with the V599E Mutant
Termination of Receptor Tyrosine Kinase Signal
Loss of the Mir-21 Allele Elevates the Expression of Its Target Genes and Reduces Tumorigenesis
The Bimodal Regulation of Epidermal Growth Factor Signaling by Human Sprouty Proteins
Supplemental Table 3 Two-Class Paired Significance Analysis of Microarrays Comparing Gene Expression Between Paired
Coordinated Activity of Spry1 and Spry2 Is Required for Normal Development of the External Genitalia
Silencing of SPRY1 Triggers Complete Regression of Rhabdomyosarcoma Tumors Carrying a Mutated RAS Gene
A Functional Genetic Screen Deines the AKT-Induced Senescence
Lack of Sprouty 1 and 2 Enhances Survival of Effector SEE COMMENTARY CD8+ T Cells and Yields More Protective Memory Cells
Frequency of Mutations in Spliceosome Genes and Poor Prognosis Isolated
Top View
Microrna-21-Mediated Regulation of Sprouty2 Protein Expression Enhances the Cytotoxic Effect of 5-Fluorouracil and Metformin in Colon Cancer Cells
Supplementary Methods
14-Rubin Yarden-Revised.P65
SPRY2 Is a Novel MET Interactor That Regulates Metastatic Potential and Differentiation in Rhabdomyosarcoma Masum Saini1, Aakanksha Verma1 and Sam J
MIG-6 and SPRY2 in the Regulation of Receptor Tyrosine Kinase Signaling: Balancing Act Via Negative Feedback Loops
The Developing Story of Sprouty and Cancer
Vertebrate Sprouty Genes and Chondrodysplasia 4467
REVIEW Sprouty Proteins
SPRED1 Mutations (Legius Syndrome): Another Clinically Useful
Evaluation of the Expression of Sprouty 1 Protein and Its Clinical Relevance in Epithelial Ovarian Cancer
FGF Signaling Inhibitor, SPRY4, Is Evolutionarily Conserved Target of WNT Signaling Pathway in Progenitor Cells
ABSTRACT Gene Expression Profiling to Understand the Alterations In
Multifunctional RNA Nanoparticles for TNBC Treatment
Atypical Role of Sprouty in Colorectal Cancer: Sprouty Repression Inhibits Epithelial–Mesenchymal Transition
Identifying Functionally Important Aberrations of Neurofibromin-1 in Non-Small Cell Lung Cancer
Concomitant Down-Regulation of SPRY1 and SPRY2 in Prostate Carcinoma
Novel Roles for the Transcriptional Repressor PRDM1 in Human Natural Killer Cells and Identification of an Inhibitor of Its Interacting Methyltransferase G9a
Cooperative Regulation of Ras/MAPK Pathway Signaling by Spredl and Neurofibromin: Insights Into the Moiecuiar Basis of Legius Syndrome